Marlene Wright Barton
President at Wright Regulatory Consulting LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eamonn Hobbs | M | 65 |
Syncromune, Inc.
 Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | 4 years |
| Charles Link | M | 64 |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | 4 years |
| Agustin Gago | M | 64 |
ImmunSYS, Inc.
 ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL.
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | 5 years |
| Dan Walsh | M | - |
Revival Healthcare Capital LLC
 Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | 6 years |
| Tony Blank | M | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Ben Avancena | M | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Nadav Tomer | M | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | 2 years |
| ALEX FORSHEY | M | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| LISA RAINONE | F | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Symeria Hudson | F | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Adam Deutsch | M | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | 1 years |
| Mark Turco | M | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Regina Benjamin | M | 67 |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Eric Roth | M | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Glenn Mattes | M | 68 |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | 6 years |
| Jeffrey Trotter | M | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Jeffrey George | M | 51 |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Douglas G. Watson | M | 79 |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | - |
| Todd Pope | M | 58 |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | 4 years |
| Lauren E. Forshey | F | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Douglas Le Fort | M | 58 |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Rachel Belsham | F | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Gregory Champion | M | 69 |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | - |
| Laxmin Laxminarain | M | 66 |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Rick Anderson | M | 63 |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | 6 years |
| Jeffrey L. Cleland | M | 59 |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | - |
| Joseph C. Maroon | M | 83 |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | - |
| Timothy Still | M | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
| Norman Schwartz | M | 74 |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | - |
| Victor Chance | M | - |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Bebel | M | - |
State University of New York at Binghamton
| 6 years |
| Peter van Amson | M | - |
State University of New York at Binghamton
| 6 years |
| Steven S. Rogers | M | 62 |
State University of New York at Binghamton
| 4 years |
| Steven Alfred Fanelli | M | - |
State University of New York at Binghamton
| 4 years |
| Jim Casey | M | - |
State University of New York at Binghamton
| 4 years |
| Steven D. Lash | M | - |
State University of New York at Binghamton
| 4 years |
| David N. Wechsler | M | - |
State University of New York at Binghamton
| 4 years |
| Warren U. Lehrenbaum | M | - |
State University of New York at Binghamton
| 3 years |
| David Rubin | M | 59 |
State University of New York at Binghamton
| 14 years |
| Lev Gonick | M | - |
State University of New York at Binghamton
| 2 years |
| David Keith Skolnik | M | - |
State University of New York at Binghamton
| 3 years |
| David Boyhan | M | - |
State University of New York at Binghamton
| 4 years |
| Patricia Kosecher | F | - |
State University of New York at Binghamton
| 4 years |
| Todd Green | M | - |
State University of New York at Binghamton
| 4 years |
| Andrew K. Chaglasian | M | - |
State University of New York at Binghamton
| 4 years |
| Richard A. Denmon | M | - |
State University of New York at Binghamton
| 4 years |
| John Kahan | M | - |
State University of New York at Binghamton
| 4 years |
| Richard Rochon | M | 66 |
State University of New York at Binghamton
| 4 years |
| Jordan M. Sherman | M | - |
State University of New York at Binghamton
| 4 years |
| Deanna Franceschini | F | - |
State University of New York at Binghamton
| 4 years |
| Phillip A. Bottari | M | - |
State University of New York at Binghamton
| 4 years |
| Gerald C. Bender | M | - |
State University of New York at Binghamton
| 4 years |
| David J. Wolfson | M | 62 |
State University of New York at Binghamton
| 4 years |
| Steve Alamin | M | 63 |
State University of New York at Binghamton
| 4 years |
| Louis Giglio | M | - |
State University of New York at Binghamton
| 4 years |
| Pamela Nelson | F | - |
State University of New York at Binghamton
| 4 years |
| Robert Appel | M | 62 |
State University of New York at Binghamton
| 4 years |
| James W. Orband | M | - |
State University of New York at Binghamton
| 4 years |
| Pamela D. Kaplan | F | - |
State University of New York at Binghamton
| 4 years |
| Kenneth A. Marvald | M | 61 |
State University of New York at Binghamton
| 4 years |
| Stacey Berner | M | - |
State University of New York at Binghamton
| 4 years |
| Orin Port | M | - |
State University of New York at Binghamton
| 4 years |
| Putterman Andrew | M | - |
State University of New York at Binghamton
| 3 years |
| Mark Behrman | M | 61 |
State University of New York at Binghamton
| 4 years |
| Joseph Patrick Byrnes | M | - |
State University of New York at Binghamton
| 4 years |
| Susan E. Giarrusso | F | - |
State University of New York at Binghamton
| 2 years |
| Jordan D. Alexander | M | - |
State University of New York at Binghamton
| 4 years |
| Karen Dunleavy | F | 65 |
State University of New York at Binghamton
| 4 years |
| Lawrence Heilbronner-Kolthoff | M | 58 |
State University of New York at Binghamton
| 4 years |
| Charles Constanti | M | 59 |
State University of New York at Binghamton
| 4 years |
| Daniel Sessa | M | 59 |
State University of New York at Binghamton
| 4 years |
| Lisa Gersh | F | 65 |
State University of New York at Binghamton
| 4 years |
| Jodi G. Waterman | F | - |
State University of New York at Binghamton
| 4 years |
| Gregg Hymowitz | M | 59 |
State University of New York at Binghamton
| 4 years |
| Bob Swan | M | 64 |
State University of New York at Binghamton
| 2 years |
| Stephen Michael Beinhacker | M | - |
State University of New York at Binghamton
| 4 years |
| Barry Gladstein | M | - |
State University of New York at Binghamton
| 4 years |
| Steven Halper | M | - |
State University of New York at Binghamton
| 4 years |
| Kenneth A. Goldblatt | M | - |
State University of New York at Binghamton
| 4 years |
| Lyle D. Feisel | M | 88 |
State University of New York at Binghamton
| 18 years |
| Jay Steven Kaplan | M | - |
State University of New York at Binghamton
| 4 years |
| Randall L. Borkenstein | M | - |
State University of New York at Binghamton
| 4 years |
| Seth Kobay | M | 69 |
State University of New York at Binghamton
| 4 years |
| Robert Garrett | M | 66 |
State University of New York at Binghamton
| 3 years |
| Allen Zwickler | M | 66 |
State University of New York at Binghamton
| 4 years |
| Robert Mancini | M | 66 |
State University of New York at Binghamton
| 4 years |
| Robert W. Richards | M | - |
State University of New York at Binghamton
| 4 years |
| John Joseph O'Rourke | M | - |
State University of New York at Binghamton
| 2 years |
| James Sanders | M | 63 |
State University of New York at Binghamton
| 3 years |
| Mitchell J. Lieberman | M | - |
State University of New York at Binghamton
| 4 years |
| Michael E. Rothman | M | - |
State University of New York at Binghamton
| 4 years |
| Gary A. Spivak | M | - |
State University of New York at Binghamton
| 4 years |
| John Daniel Mohr | M | 58 |
State University of New York at Binghamton
| 4 years |
| David M. Friedman | M | - |
State University of New York at Binghamton
| 4 years |
| Andrew Hamer | M | 60 |
State University of New York at Binghamton
| 4 years |
| David Kieselstein | M | - |
State University of New York at Binghamton
| 4 years |
| David Polson | M | - |
State University of New York at Binghamton
| 4 years |
| Michael Nemeroff | M | 61 |
State University of New York at Binghamton
| 4 years |
| William Feldman | M | 60 |
State University of New York at Binghamton
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marlene Wright Barton
- Personal Network
